David M. Urso - Jun 2, 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
President and CEO, Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Stock symbol
MEIP
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2023, 04:37 PM
Previous filing
Jul 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +167K $0.00 167K Jun 2, 2023 Common Stock 167K $7.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.